Terumo (TSE:4543) Moat Score: 6/10 (As of Jul. 12, 2026)


TSE:4543 Terumo Corp TSE:4543
88 GF Score
Price 円2,189.00
GF Value 円3,137.22
Valuation Significantly Undervalued
View Full Analysis

What is Terumo Moat Score?

Terumo TSE:4543 -1.73% 88 Moat Score is 6 as of Jul. 12, 2026. GuruFocus rates TSE:4543 with a GF Score™ of 88/100 and a GF Value™ of 円3,137.22 (Significantly Undervalued). Among 843 Medical Devices & Instruments companies, Terumo ranks better than 95.73% on this metric.

Terumo has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Terumo has Narrow Moat: Terumo Corp benefits from strong brand recognition and significant intellectual property in the medical devices sector. It has a solid distribution network and moderate pricing power. However, while it has durable advantages, these are not sufficient to classify as a wide moat due to competitive pressures and regulatory challenges.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Terumo might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Terumo  (TSE:4543) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Terumo Moat Score Related Terms

TSE:4543 vs ISRG, BDX, MDLN: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Terumo's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Terumo Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Moat Score distribution charts can be found below:

* The bar in red indicates where Terumo's Moat Score falls into.


TSE:4543
88GF Score
Terumo Corp TSE:4543
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Terumo (TSE:4543) has a Moat Score of 6 as of Jul. 12, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Terumo ranks #36 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Terumo's Moat Score too high?
Terumo's current Moat Score is 6. Based on the distribution chart, Terumo ranks #36 out of 843 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Terumo has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Moat Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Terumo ranks #36 out of 843 companies for Moat Score. This places Terumo in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Terumo's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TSE:4543) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,137.22, compared to a current price of 円2,189.00 — trading 30.2% below its estimated fair value. The current Moat Score is 6. Terumo's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Terumo (TSE:4543), the current Moat Score is 6 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (TSE:4543) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of 円2,189.00 is trading 30.2% below its estimated GF Value™ of 円3,137.22. GuruFocus considers Terumo to be Significantly Undervalued.

Key valuation signals for TSE:4543:

  • Moat Score: 6
  • GF Value™: 円3,137.22 vs. price of 円2,189.00 (30.2% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the TSE:4543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
88GF Score

Get the complete analysis for TSE:4543

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,189.00
Price
円3,137.22
GF Value